sevoflurane has been researched along with Hamartoma Syndrome, Multiple in 1 studies
Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
Hamartoma Syndrome, Multiple: A hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Facial trichilemmomas and papillomatous papules of the oral mucosa are the most characteristic lesions. Individuals with this syndrome have a high risk of BREAST CANCER; THYROID CANCER; and ENDOMETRIAL CANCER. This syndrome is associated with mutations in the gene for PTEN PHOSPHATASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pancaro, C | 1 |
| Miller, T | 1 |
| Dingeman, RS | 1 |
1 other study available for sevoflurane and Hamartoma Syndrome, Multiple
| Article | Year |
|---|---|
Anesthetic management of a child with Bannayan-Riley-Ruvalcaba syndrome.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Child; Female; Hamartoma Syndrome, Multiple; Hema | 2008 |